First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $170.96 and traded as high as $172.80. First Trust NYSE Arca Biotechnology Index Fund shares last traded at $172.67, with a volume of 19,208 shares traded.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The stock has a 50-day moving average price of $171.04 and a 200-day moving average price of $163.89. The company has a market capitalization of $1.32 billion, a P/E ratio of 17.20 and a beta of 0.86.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
Institutional investors have recently bought and sold shares of the company. Synovus Financial Corp bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 3rd quarter worth about $203,000. MML Investors Services LLC increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 2.2% in the third quarter. MML Investors Services LLC now owns 3,888 shares of the company’s stock worth $669,000 after purchasing an additional 84 shares in the last quarter. Orion Portfolio Solutions LLC acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the third quarter valued at approximately $912,000. Stifel Financial Corp boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.1% during the 3rd quarter. Stifel Financial Corp now owns 34,377 shares of the company’s stock worth $5,910,000 after buying an additional 1,339 shares in the last quarter. Finally, HighTower Advisors LLC grew its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.0% during the 3rd quarter. HighTower Advisors LLC now owns 16,360 shares of the company’s stock worth $2,817,000 after buying an additional 156 shares during the period.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- 3 REITs to Buy and Hold for the Long Term
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What to Know About Investing in Penny Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Quiet Period Expirations Explained
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.